Cancer Development and Progression

Mei He, Jennifer Rosen, David Mangiameli, Steven Libutti

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations (Scopus)

Abstract

Cancer development and progression is a complex process that involves a host of functional and genetic abnormalities. Genomic perturbations and the gene expression they lead to, can now be globally identified with the use of DNA microarray. This relatively new technology has forever changed the scale of biological investigation. The enormous amount of data generated via a single chip has led to major global studies of the cellular processes underlying malignant transformation and progression. The multiplicity of platforms from different proprietors has offered investigators flexibility in their experimental design. Additionally, there are several more recent microarrays whose designs were inspired by the nucleotide-based technology. These include protein, multi-tissue, cell, and interference RNA microarrays. Combinations of microarray and other contemporary scientific methods, such as, laser capture microdissection (LCM), comparative genomic hybridization (CGH), single nude-otide polymorphism analysis (SNP) and chromatin immunoprecipitation (ChIP), have created entirely new fields of interest in the more global quest to better define the molecular basis of malignancy. In addition to basic science applications, many clinical inquiries have been performed. These queries have shown microarray to have clinical utility in cancer diagnosis, risk stratification, and patient management.

Original languageEnglish (US)
Title of host publicationMicroarray Technology and Cancer Gene Profiling
PublisherSpringer New York
Pages117-133
Number of pages17
ISBN (Print)9780387399775
DOIs
StatePublished - Jan 1 2007

Publication series

NameAdvances in Experimental Medicine and Biology
Volume593
ISSN (Print)0065-2598

Fingerprint

Microarrays
Laser Capture Microdissection
Technology
Neoplasms
Comparative Genomic Hybridization
Chromatin Immunoprecipitation
RNA Interference
Oligonucleotide Array Sequence Analysis
Microdissection
Research Design
Nucleotides
Research Personnel
Gene Expression
Polymorphism
Gene expression
Design of experiments
Chromatin
RNA
Tissue
Proteins

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

He, M., Rosen, J., Mangiameli, D., & Libutti, S. (2007). Cancer Development and Progression. In Microarray Technology and Cancer Gene Profiling (pp. 117-133). (Advances in Experimental Medicine and Biology; Vol. 593). Springer New York. https://doi.org/10.1007/978-0-387-39978-2_12
He, Mei ; Rosen, Jennifer ; Mangiameli, David ; Libutti, Steven. / Cancer Development and Progression. Microarray Technology and Cancer Gene Profiling. Springer New York, 2007. pp. 117-133 (Advances in Experimental Medicine and Biology).
@inbook{14e719122a1b426e98918a715490cc79,
title = "Cancer Development and Progression",
abstract = "Cancer development and progression is a complex process that involves a host of functional and genetic abnormalities. Genomic perturbations and the gene expression they lead to, can now be globally identified with the use of DNA microarray. This relatively new technology has forever changed the scale of biological investigation. The enormous amount of data generated via a single chip has led to major global studies of the cellular processes underlying malignant transformation and progression. The multiplicity of platforms from different proprietors has offered investigators flexibility in their experimental design. Additionally, there are several more recent microarrays whose designs were inspired by the nucleotide-based technology. These include protein, multi-tissue, cell, and interference RNA microarrays. Combinations of microarray and other contemporary scientific methods, such as, laser capture microdissection (LCM), comparative genomic hybridization (CGH), single nude-otide polymorphism analysis (SNP) and chromatin immunoprecipitation (ChIP), have created entirely new fields of interest in the more global quest to better define the molecular basis of malignancy. In addition to basic science applications, many clinical inquiries have been performed. These queries have shown microarray to have clinical utility in cancer diagnosis, risk stratification, and patient management.",
author = "Mei He and Jennifer Rosen and David Mangiameli and Steven Libutti",
year = "2007",
month = "1",
day = "1",
doi = "10.1007/978-0-387-39978-2_12",
language = "English (US)",
isbn = "9780387399775",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York",
pages = "117--133",
booktitle = "Microarray Technology and Cancer Gene Profiling",
address = "United States",

}

He, M, Rosen, J, Mangiameli, D & Libutti, S 2007, Cancer Development and Progression. in Microarray Technology and Cancer Gene Profiling. Advances in Experimental Medicine and Biology, vol. 593, Springer New York, pp. 117-133. https://doi.org/10.1007/978-0-387-39978-2_12

Cancer Development and Progression. / He, Mei; Rosen, Jennifer; Mangiameli, David; Libutti, Steven.

Microarray Technology and Cancer Gene Profiling. Springer New York, 2007. p. 117-133 (Advances in Experimental Medicine and Biology; Vol. 593).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Cancer Development and Progression

AU - He, Mei

AU - Rosen, Jennifer

AU - Mangiameli, David

AU - Libutti, Steven

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Cancer development and progression is a complex process that involves a host of functional and genetic abnormalities. Genomic perturbations and the gene expression they lead to, can now be globally identified with the use of DNA microarray. This relatively new technology has forever changed the scale of biological investigation. The enormous amount of data generated via a single chip has led to major global studies of the cellular processes underlying malignant transformation and progression. The multiplicity of platforms from different proprietors has offered investigators flexibility in their experimental design. Additionally, there are several more recent microarrays whose designs were inspired by the nucleotide-based technology. These include protein, multi-tissue, cell, and interference RNA microarrays. Combinations of microarray and other contemporary scientific methods, such as, laser capture microdissection (LCM), comparative genomic hybridization (CGH), single nude-otide polymorphism analysis (SNP) and chromatin immunoprecipitation (ChIP), have created entirely new fields of interest in the more global quest to better define the molecular basis of malignancy. In addition to basic science applications, many clinical inquiries have been performed. These queries have shown microarray to have clinical utility in cancer diagnosis, risk stratification, and patient management.

AB - Cancer development and progression is a complex process that involves a host of functional and genetic abnormalities. Genomic perturbations and the gene expression they lead to, can now be globally identified with the use of DNA microarray. This relatively new technology has forever changed the scale of biological investigation. The enormous amount of data generated via a single chip has led to major global studies of the cellular processes underlying malignant transformation and progression. The multiplicity of platforms from different proprietors has offered investigators flexibility in their experimental design. Additionally, there are several more recent microarrays whose designs were inspired by the nucleotide-based technology. These include protein, multi-tissue, cell, and interference RNA microarrays. Combinations of microarray and other contemporary scientific methods, such as, laser capture microdissection (LCM), comparative genomic hybridization (CGH), single nude-otide polymorphism analysis (SNP) and chromatin immunoprecipitation (ChIP), have created entirely new fields of interest in the more global quest to better define the molecular basis of malignancy. In addition to basic science applications, many clinical inquiries have been performed. These queries have shown microarray to have clinical utility in cancer diagnosis, risk stratification, and patient management.

UR - http://www.scopus.com/inward/record.url?scp=84934441284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934441284&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-39978-2_12

DO - 10.1007/978-0-387-39978-2_12

M3 - Chapter

SN - 9780387399775

T3 - Advances in Experimental Medicine and Biology

SP - 117

EP - 133

BT - Microarray Technology and Cancer Gene Profiling

PB - Springer New York

ER -

He M, Rosen J, Mangiameli D, Libutti S. Cancer Development and Progression. In Microarray Technology and Cancer Gene Profiling. Springer New York. 2007. p. 117-133. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-0-387-39978-2_12